Communiqués ADC Therapeutics SA

Actions

ADCT

CH0499880968

Recherche biotechnologique et médicale

Temps réel estimé Cboe BZX 20:58:51 12/10/2026			Varia. 5j.	Varia. 1 janv.
1,865 ^USD	+7,80 %		+51,22 %	-47,31 %

09/10	ADC Therapeutics réduit sa dette et étend sa visibilité financière avant la publication de données clés sur son médicament, selon RBC	MT
08/10	Les actions d’ADC Therapeutics progressent après une restructuration financière qui prolonge sa visibilité de trésorerie	MT

Communiqués

08/10	ADC Therapeutics Announces Comprehensive Strategic Financial Restructuring Marking Key Capital Structure Improvements	PR
03/09	ADC Therapeutics to Participate in the 2026 Cantor Global Healthcare Conference	PR
13/08	ADC Therapeutics Reports Second Quarter 2026 Financial Results and Provides Operational Updates	PR
06/08	ADC Therapeutics to Host Second Quarter 2026 Financial Results Conference Call on August 13, 2026	PR
01/07	ADC Therapeutics Announces New Employee Inducement Grant	PR
30/06	ADC Therapeutics Announces Completion of Enrollment in LOTIS-7 Phase 1b ZYNLONTA® Combination Trial	PR
24/06	ADC Therapeutics Announces Strategic Reorganization to Support ZYNLONTA® Growth Opportunities and Regulatory Priorities	PR
03/06	ADC Therapeutics Announces Results From LOTIS-5 Phase 3 Confirmatory Clinical Trial of ZYNLONTA® in Combination with Rituximab in Relapsed or Refractory Diffuse Large B-Cell Lymphoma	PR
04/05	ADC Therapeutics : (ADCT 1Q 2026 Earnings)	PU
04/05	ADC Therapeutics Reports First Quarter 2026 Financial Results and Provides Operational Updates	PR
01/05	ADC Therapeutics Makes Grants to New Employees Under Inducement Plan	PR
27/04	ADC Therapeutics to Host First Quarter 2026 Financial Results Conference Call on May 4, 2026	PR
01/04	ADC Therapeutics Announces New Employee Inducement Grant	PR
10/03	ADC Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Operational Update	PR
03/03	ADC Therapeutics to Host Fourth Quarter and Full Year 2025 Financial Results Conference Call on March 10, 2026	PR
02/03	ADC Therapeutics Makes Grants to New Employees Under Inducement Plan	PR
24/02	ADC Therapeutics to Participate in March Investor Conferences	PR
23/02	ADC Therapeutics Announces Amended HealthCare Royalty Financing Agreement	PR
02/02	ADC Therapeutics Makes Grants to New Employees Under Inducement Plan	PR
30/01	$170B Patent Cliff Ignites Biotech Deal Wave: Late-Stage Platforms Command Premium	PR
12/01	ADC Therapeutics : (JPMUpdateJan2026 010826)	PU
12/01	ADC Therapeutics : Presentation (JPMUpdateJan2026 010826)	PU
08/01	ADC Therapeutics Provides Preliminary Fourth Quarter and Full Year 2025 Revenue and Cash Estimates and Recent Corporate Updates	PR
08/01	ADC Therapeutics to Participate in the 44th Annual J.P. Morgan Healthcare Conference	PR
02/01	ADC Therapeutics Announces New Employee Inducement Grant	PR